Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Lidocaine for Recovery After Cesarean Delivery
NCT02257346Withdrawn
- Sponsor
- Northwestern University
- Start
- Nov 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain (2 arms), sponsored by Northwestern University. Primary endpoint: Quality of Recovery 40 at 1 day. Planned start Nov 2014; status: withdrawn.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02257346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02257346.